Can Cannabis 2.0 Products Boost Canopy Growth and Organigram in 2020?
There was a whole lot of hype after "Cannabis 2.0" happened in Canada in October 2019. It marked the second wave of recreational marijuana legalization in Canada. Cannabis 2.0 included cannabis derivatives products -- namely cannabis-infused edibles, chocolates, beverages, vapes, and concentrates -- while Cannabis 1.0 in October 2018 only legalized cannabis flowers and buds.
While all marijuana companies ramped up production to grab the opportunities of this new market, Canopy Growth (NYSE: CGC) and Organigram Holdings (NASDAQ: OGI) have focused on providing the most innovative products to consumers. Surprisingly, while the COVID-19 pandemic has forced many to focus on conserving cash, these two are moving ahead with the launch of more derivatives products for this year.
Source Fool.com